Role of Nucleobindin-2 in the Clinical Pathogenesis and Treatment Resistance of Glioblastoma

Glioblastoma (GBM) stands as the most prevalent primary malignant brain tumor, typically resulting in a median survival period of approximately thirteen to fifteen months after undergoing surgery, chemotherapy, and radiotherapy. Nucleobindin-2 (NUCB2) is a protein involved in appetite regulation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, I-Cheng, Chang, Chih-Hui, Chong, Yoon Bin, Kuo, Shih-Hsun, Cheng, Yu-Wen, Lieu, Ann-Shung, Tseng, Tzu-Ting, Lin, Chien-Ju, Tsai, Hung-Pei, Kwan, Aij-Lie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572158/
https://www.ncbi.nlm.nih.gov/pubmed/37830634
http://dx.doi.org/10.3390/cells12192420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572158/
https://www.ncbi.nlm.nih.gov/pubmed/37830634
http://dx.doi.org/10.3390/cells12192420

Ejemplares similares